Patent · US Active

Methods and compositions for paper-based and hybrid microfluidic devices integrated with nucleic acid amplification for disease diagnosis

US10875024B2 · kind B2 · utility

6Cited by

2References

10Claims

0Family size

Assignee

The Board of Regents of the University of Texas System · US

Inventors

Xiujun Li · Seattle, US
Maowei Dou · El Paso, US
Delfina Dominguez · El Paso, US

Key dates

Filing date	Jul 10, 2015
Grant date	Dec 29, 2020
Priority date	—
Expiry date	Nov 24, 2037

Classification

Technology area (CPC B)Performing Operations; Transporting
CPC primaryB01L2300/126
WIPO fieldChemical engineering
WIPO sectorChemistry

Abstract

Certain embodiments are directed to paper and its hybrid microfluidic devices integrated with nucleic acid amplification for simple, cost-effective, rapid, and sensitive pathogen detection, especially in low-resource settings.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.